Faithful Mouse Modeling of Human Lung Cancer
人类肺癌的忠实小鼠模型
基本信息
- 批准号:10538424
- 负责人:
- 金额:$ 38.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Abstract
Lung cancer is the leading cause of cancer-related deaths in both men and women with a 5-year survival rate
of only 19%. Although PD-1 immune checkpoint blockade therapy may improve these outcomes, the majority
of lung cancer patients still fail this innovative immunotherapy. One major obstacle in the lung cancer field is
the lack of faithful models that are suitable to identify mechanisms underlying the initiation and progression and
metastasis of human lung cancer and to test new therapeutic strategies against this number 1 cancer killer.
Xenograft, syngeneic or humanized mouse models using established cancer cell lines cannot recapitulate the
natural coevolution of cancer and stromal cells as well as their intricate interplay in the complex micro-
environment. Furthermore, using immunocompromised mice for xenograft transplants precludes the critical
interaction between cancer cells and the immune system. To meet this important challenge, we have recently
generated a novel mouse model of lung cancer, with the full process from tumor initiation to regional and
distant metastasis at a penetrance of 100%. Notably, the metastasis pattern in this endogenous lung cancer
model closely resembles that of its human counterpart in patients. In this application we will systematically
characterize this model, and importantly, examine if it replicates human lung cancer molecularly, genetically
and immuno-phenotypically. We will also establish several complementary models and incorporate them with
the imaging markers luciferase and enhanced green fluorescent protein (EGFP) allowing monitoring and
tracking tumor development and metastasis non-invasively in vivo. These studies will establish faithful models
and provide fundamental knowledge on human lung cancer. They are also highly significant to the cancer field
at large, given the currently limited knowledge on cancer, and in particular, the full process from tumor initiation
to regional and distant metastasis in general.
摘要
肺癌是男性和女性癌症相关死亡的主要原因,5年生存率
只有19%。虽然PD-1免疫检查点阻断疗法可能改善这些结果,但大多数人认为,
的肺癌患者仍然无法通过这种创新的免疫疗法。肺癌领域的一个主要障碍是
缺乏可靠的模型,适合于确定启动和进展的机制,
转移的人类肺癌,并测试针对这一头号癌症杀手的新治疗策略。
使用已建立的癌细胞系的异种移植物、同基因或人源化小鼠模型不能重现本发明。
癌症和基质细胞的自然共同进化,以及它们在复杂的微环境中错综复杂的相互作用,
环境此外,使用免疫功能低下的小鼠进行异种移植排除了关键的免疫缺陷。
癌细胞和免疫系统之间的相互作用。为了迎接这一重大挑战,我们最近
建立了一种新的小鼠肺癌模型,包括从肿瘤发生到区域和
远处转移率100%。值得注意的是,这种内源性肺癌的转移模式
模型与患者体内的人类模型非常相似。在本申请中,我们将系统地
描述这个模型,重要的是,检查它是否在分子上,遗传上复制了人类肺癌,
和免疫表型。我们还将建立几个补充模型,并将其与
成像标记荧光素酶和增强型绿色荧光蛋白(EGFP)允许监测和
在体内非侵入性地跟踪肿瘤发展和转移。这些研究将建立可靠的模型
并提供人类肺癌的基础知识。它们对癌症领域也具有重要意义
总体而言,鉴于目前对癌症的知识有限,特别是从肿瘤发生的整个过程,
区域性和远处转移。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUTIAN XIAO其他文献
GUTIAN XIAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUTIAN XIAO', 18)}}的其他基金
PDLIM2 as a cancer and chemosensitizing target
PDLIM2 作为癌症和化疗增敏靶点
- 批准号:
8685914 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
PDLIM2 as a cancer and chemosensitizing target
PDLIM2 作为癌症和化疗增敏靶点
- 批准号:
9265025 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
PDLIM2 as a cancer and chemosensitizing target
PDLIM2 作为癌症和化疗增敏靶点
- 批准号:
8575709 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
HTLV 对肿瘤中 NF-kappaB2 p100 加工的失调
- 批准号:
7494730 - 财政年份:2006
- 资助金额:
$ 38.83万 - 项目类别:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
HTLV 对肿瘤中 NF-kappaB2 p100 加工的失调
- 批准号:
7102359 - 财政年份:2006
- 资助金额:
$ 38.83万 - 项目类别:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
HTLV 对肿瘤中 NF-kappaB2 p100 加工的失调
- 批准号:
7822944 - 财政年份:2006
- 资助金额:
$ 38.83万 - 项目类别:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
HTLV 对肿瘤中 NF-kappaB2 p100 加工的失调
- 批准号:
7406605 - 财政年份:2006
- 资助金额:
$ 38.83万 - 项目类别:
相似海外基金
Decoding Hippocampal-Parietal contributions to spatial navigation in a mouse modeling Tau and AB aggregation features of Alzheimer's Disease
解码海马顶叶对阿尔茨海默病 Tau 和 AB 聚集特征建模小鼠空间导航的贡献
- 批准号:
10707032 - 财政年份:2022
- 资助金额:
$ 38.83万 - 项目类别:
Decoding Hippocampal-Parietal contributions to spatial navigation in a mouse modeling Tau and AB aggregation features of Alzheimer's Disease
解码海马顶叶对阿尔茨海默病 Tau 和 AB 聚集特征建模小鼠空间导航的贡献
- 批准号:
10537553 - 财政年份:2022
- 资助金额:
$ 38.83万 - 项目类别:
Modeling Prenatal COVID-19 Exposure Using Human Cortical Organoids and Mouse Models
使用人类皮质类器官和小鼠模型模拟产前 COVID-19 暴露
- 批准号:
10390067 - 财政年份:2022
- 资助金额:
$ 38.83万 - 项目类别:
Modeling and mechanistic investigation of a novel dry AMD mouse model with CLIC4 deleted in RPE
RPE 中删除 CLIC4 的新型干 AMD 小鼠模型的建模和机制研究
- 批准号:
10475752 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain
在嵌合小鼠大脑中模拟 HIV 小胶质细胞相关的感染和炎症
- 批准号:
10458060 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Modeling activity-dependent gene expression in mouse embryonic stem cell-derived neurons
模拟小鼠胚胎干细胞衍生神经元的活性依赖性基因表达
- 批准号:
563560-2021 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
University Undergraduate Student Research Awards
Modeling and mechanistic investigation of a novel dry AMD mouse model with CLIC4 deleted in RPE
RPE 中删除 CLIC4 的新型干 AMD 小鼠模型的建模和机制研究
- 批准号:
10279736 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain
在嵌合小鼠大脑中模拟 HIV 小胶质细胞相关的感染和炎症
- 批准号:
10632139 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别: